With a big stake in hand, Samantha Du files for $115M IPO for Zai Lab
In three years Shanghai-based Zai Lab has in-licensed a pipeline of 6 clinical-stage therapeutics from a group of small and large global players, moved to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
